Territorial Availability: Available through Bertin Technologies only in France
- Synonyms
- 6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
- Correlated keywords
- 110158-59-3 407610-62-2 AM-833 Megalocin Megalone Quinodis Ro236240 Ro-236240 anti-biotic Pseudomonas Haemophilus Neisseria Branhamella Campylobacter Escherichia Flerofloxacin Ro 23-6240/000 23624000 anti-biotic UTI
- Product Overview:
Fleroxacin is a broad-spectrum fluoroquinolone antibiotic.{38988} It is active against a variety of Gram-positive and Gram-negative bacteria with MIC90 values ranging from 0.05 to 3.13 µg/ml for clinical isolates of Staphylococcus, P. aeruginosa, H. influenzae, N. gonorrhoeae, B. catarrhalis, C. jejuni, and various species of Enterobacteriaceae. Fleroxacin inhibits bacterial DNA replication with IC50 values of 82.6 and 31.6 µg/ml for S. aureus DNA gyrase and topoisomerase IV, respectively.{27493} Fleroxacin is active in vivo with ED50 values ranging from 0.8 to 16.6 mg/kg in mice with systemic bacterial infections.{38988} It also reduces E. coli in the kidney in a mouse model of urinary tract infection when administered at doses of 0.625 and 10 mg/kg twice daily. Formulations containing fleroxacin have been used in the treatment of uncomplicated cystitis, gonorrhea, bacterial enteritis, traveler’s diarrhea, and urinary tract infections.{38989}
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.